Boris Vuillermoz

The small leucine-rich proteoglycan lumican inhibits melanoma progression

Boris Vuillermoz, Marie-France D’Onofrio, Laurent Ramont et al. · Experimental Cell Research · 2004 · 133 citations

Medicine, Cancer Biology, Oncology +12

Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism

Marije B. Overdijk, Kristin Strumane, Frank J. Beurskens et al. · Molecular Cancer Therapeutics · 2020 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Lumican inhibits B16F1 melanoma cell lung metastasis.

Stéphane Brézillon, Cédric Zeltz, Lars Schneider et al. · PubMed · 2009 · 56 citations

Medicine, Cell Biology, Oncology +14

Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts

Boris Vuillermoz, Yanusz Wegrowski, Jean‐Luc Contet‐Audonneau et al. · Molecular and Cellular Biochemistry · 2005 · 50 citations

Life Sciences, Biochemistry, Dermatology +13

Specific Protein-1 Is a Universal Regulator of UDP-glucose Dehydrogenase Expression

Yannick Bontemps, Boris Vuillermoz, Frank Antonicelli et al. · Journal of Biological Chemistry · 2003 · 46 citations · Full text

Life Sciences, Biochemistry, Genetics +15